Connection
Joel Marrs to Cardiovascular Diseases
This is a "connection" page, showing publications Joel Marrs has written about Cardiovascular Diseases.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.898 |
|
|
|
-
Marrs JC, Haidar CE. ASHP Statement on Pharmacist Prescribing of Statins. Am J Health Syst Pharm. 2022 11 22; 79(23):2182-2184.
Score: 0.383
-
Marrs JC. Optimizing outcomes in patients with cardiovascular disease and chronic kidney disease. Am J Manag Care. 2011 Dec; 17 Suppl 15:S403-11.
Score: 0.179
-
Marrs JC, Saseen JJ. Effects of lipid-lowering therapy on reduction of cardiovascular events in patients with end-stage renal disease requiring hemodialysis. Pharmacotherapy. 2010 Aug; 30(8):823-9.
Score: 0.163
-
Marrs JC, Kostoff MD. Discontinuation of Statins: What Are the Risks? Curr Atheroscler Rep. 2016 Jul; 18(7):41.
Score: 0.062
-
Fosmire Rundgren EW, Anderson SL, Marrs JC. Evaluation of aspirin use in patients with diabetes receiving care in community health. Ann Pharmacother. 2015 Feb; 49(2):170-7.
Score: 0.055
-
Marrs JC. Colesevelam for the management of type 2 diabetes. Expert Opin Drug Metab Toxicol. 2009 Feb; 5(2):187-94.
Score: 0.037
-
Wiggins BS, Dixon D, Bellone J, Gasbarro N, Marrs JC, Tran R. Key Articles and Guidelines in the Management of Dyslipidemia: 2019 Update. J Pharm Pract. 2020 Dec; 33(6):882-894.
Score: 0.019